Zhejiang Yatai Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Zhejiang Yatai Pharmaceutical has a total shareholder equity of CN¥625.4M and total debt of CN¥606.6M, which brings its debt-to-equity ratio to 97%. Its total assets and total liabilities are CN¥1.4B and CN¥732.6M respectively.
Key information
97.0%
Debt to equity ratio
CN¥606.59m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥689.10m |
| Equity | CN¥625.43m |
| Total liabilities | CN¥732.60m |
| Total assets | CN¥1.36b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002370's short term assets (CN¥904.6M) exceed its short term liabilities (CN¥686.1M).
Long Term Liabilities: 002370's short term assets (CN¥904.6M) exceed its long term liabilities (CN¥46.5M).
Debt to Equity History and Analysis
Debt Level: 002370 has more cash than its total debt.
Reducing Debt: 002370's debt to equity ratio has increased from 40.8% to 97% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 002370 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 002370 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 65.5% per year.